Table 2: MoCA scores for patients with severe CAS and for control subjects with severe PAD.
|
CAS (n=55) |
PAD (n=54) |
p value |
Effect Size, R |
|
Median |
Q1 |
Q3 |
Median |
Q1 |
Q3 |
| MoCA Total Score |
24 |
23 |
26 |
26 |
25 |
28 |
0.005 |
0.3 |
| MoCA Subtests: |
|
|
| VSE |
4 |
3 |
5 |
4 |
4 |
5 |
0.128 |
0.16 |
| Naming |
3 |
3 |
3 |
3 |
3 |
3 |
0.419 |
0.08 |
| Attention |
5 |
5 |
6 |
6 |
5 |
6 |
0.142 |
0.16 |
| Language |
2 |
1 |
2 |
2 |
1 |
2 |
0.661 |
0.05 |
| Abstraction |
2 |
1 |
2 |
2 |
1 |
2 |
0.773 |
0.03 |
| Delayed Recall |
2 |
1 |
4 |
3.5 |
2 |
5 |
0.023 |
0.24 |
| Orientation |
6 |
6 |
6 |
6 |
6 |
6 |
0.684 |
0.04 |
CAS, carotid artery stenosis; PAD, lower extremity peripheral artery disease; MoCA, Montreal Cognitive Assessment Scale; VSE, visuospatial/executive functions